Chemotherapy Prior to RAPA-201 Therapy Clinical Trials (2026): 3 Studies for Malignant Melanoma & Head and Neck Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 Chemotherapy Prior to RAPA-201 Therapy clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 3 indications (including Malignant Melanoma & Head and Neck Cancer) and 117 total planned enrollment. 2 Chemotherapy Prior to RAPA-201 Therapy clinical trials are actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT06708455 (Sep 2029).
Where to Participate: All Chemotherapy Prior to RAPA-201 Therapy Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting Chemotherapy Prior to RAPA-201 Therapytrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| NJ | Hackensack University Medical Center | Hackensack07601 | NCT05144698 | Map |
Chemotherapy Prior to RAPA-201 Therapy clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | not yet recruiting | Total |
|---|---|---|---|---|
| P1/P2 | 1 | 1 | ||
| P2 | 1 | 1 | 2 |
Recruiting Chemotherapy Prior to RAPA-201 Therapy clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06708455 | LPhase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma | P2 | Malignant Melanoma With Metastasis | 65 | Mar 2027 |
| NCT05144698 | RAPA-201 Therapy of Solid Tumors | P1/P2 | Solid Tumor | 37 | Aug 2021 |
Chemotherapy Prior to RAPA-201 Therapy clinical trials by indication
Malignant Melanoma With Metastasis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06708455 | L | P2 | not yet recruiting | Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma |
Solid Tumor (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05144698 | — | P1/P2 | recruiting | RAPA-201 Therapy of Solid Tumors |
Relapsed, Refractory Multiple Myeloma (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04176380 | — | P2 | completed | RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma |
Chemotherapy Prior to RAPA-201 Therapy pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| L | NCT06708455 | P2 | not yet recruiting | Malignant Melanoma With Metastasis | 65 | — |
All Chemotherapy Prior to RAPA-201 Therapy trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06708455 | L | Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma | P2 | not yet recruiting | 65 | Rapa Therapeutics LLC | Mar 2027 |
| NCT05144698 | RAPA-201 Therapy of Solid Tumors | P1/P2 | recruiting | 37 | Rapa Therapeutics LLC | Aug 2021 | |
| NCT04176380 | RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma | P2 | completed | 15 | Rapa Therapeutics LLC | Dec 2020 |
Chemotherapy Prior to RAPA-201 Therapy clinical trials: frequently asked questions
- How many Chemotherapy Prior to RAPA-201 Therapy clinical trials are there?
- 3 Chemotherapy Prior to RAPA-201 Therapy clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 1 is marked completed.
- Are Chemotherapy Prior to RAPA-201 Therapy clinical trials recruiting in 2026?
- Yes — 1 Chemotherapy Prior to RAPA-201 Therapy trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is Chemotherapy Prior to RAPA-201 Therapy being studied for?
- Chemotherapy Prior to RAPA-201 Therapy is being studied for Malignant Melanoma, Head and Neck Cancer, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV, Malignant Melanoma With Metastasis and 8 more. The trials are grouped by indication on this page.
- What phase is Chemotherapy Prior to RAPA-201 Therapy in?
- Chemotherapy Prior to RAPA-201 Therapy clinical trials span 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Chemotherapy Prior to RAPA-201 Therapy clinical trials?
- The lead sponsor across the most Chemotherapy Prior to RAPA-201 Therapy trials is Rapa Therapeutics LLC. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Chemotherapy Prior to RAPA-201 Therapyas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: